INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.400
-0.070 (-4.76%)
Apr 28, 2026, 4:00 PM EDT - Market closed
INmune Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -45.93 | -42.08 | -30.01 | -27.3 | -30.34 | |
| Depreciation & Amortization | 0.08 | - | - | - | - | |
| Other Amortization | - | 0.08 | 0.22 | 0.24 | 0.13 | |
| Asset Writedown & Restructuring Costs | 16.51 | - | - | 0.09 | - | |
| Stock-Based Compensation | 9.91 | 7.61 | 7.37 | 7.15 | 4.8 | |
| Other Operating Activities | -0.63 | - | - | - | - | |
| Change in Accounts Payable | 1.86 | -1.37 | 2.72 | 1.4 | 2.26 | |
| Change in Other Net Operating Assets | -4.39 | 2.41 | 7.72 | -4.27 | -5.35 | |
| Operating Cash Flow | -22.58 | -33.36 | -11.98 | -22.69 | -28.5 | |
| Capital Expenditures | -1.04 | - | - | - | - | |
| Other Investing Activities | - | - | - | - | -15 | |
| Investing Cash Flow | -1.04 | - | - | - | -15 | |
| Long-Term Debt Issued | - | - | - | - | 14.95 | |
| Total Debt Issued | - | - | - | - | 14.95 | |
| Long-Term Debt Repaid | - | -10 | -5 | - | - | |
| Net Debt Issued (Repaid) | - | -10 | -5 | - | 14.95 | |
| Issuance of Common Stock | 27.55 | 28.21 | 0.78 | 0.73 | 81.41 | |
| Other Financing Activities | 0.07 | - | - | - | - | |
| Financing Cash Flow | 27.61 | 18.21 | -4.23 | 0.73 | 96.36 | |
| Foreign Exchange Rate Adjustments | -0.16 | 0.22 | -0.1 | -0.7 | -0.01 | |
| Net Cash Flow | 3.83 | -14.93 | -16.31 | -22.66 | 52.84 | |
| Free Cash Flow | -23.62 | -33.36 | -11.98 | -22.69 | -28.5 | |
| Free Cash Flow Margin | -47248.00% | -238292.86% | -7729.03% | -6065.77% | -15748.07% | |
| Free Cash Flow Per Share | -0.95 | -1.67 | -0.67 | -1.26 | -1.77 | |
| Cash Interest Paid | - | 1.69 | 1.78 | 1.37 | 0.56 | |
| Levered Free Cash Flow | -13.03 | -18.45 | -1.4 | -13.27 | -16.53 | |
| Unlevered Free Cash Flow | -13.03 | -18.03 | -0.2 | -12.25 | -16.66 | |
| Change in Working Capital | -2.53 | 1.04 | 10.44 | -2.86 | -3.09 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.